Vaguely worded laws worldwide have increasingly put doctors at risk of legal reprisal for doing their jobs, with comments from our Len Rubenstein

Quick Read

Is it ethical to break cost-controlling rules for a patient’s benefit?

Quick Read

New report on how counter-terrorism law is being used to deprive people of health care and to punish health workers who provide it, both contrary to international law and long-held norms. Report authors include our Len Rubenstein

Quick Read

The Food and Drug Administration defines a drug shortage as a “period of time when the demand or projected demand for a medically necessary drug in the U.S. exceeds its supply.” All too often, a shortage means that doctors cannot give the right drugs to patients when needed

Quick Read

Texas Fold ‘Em

June 8, 2018

In an unexpected move, the Justice Department filed a brief this evening urging a Texas court to invalidate the Affordable Care Act’s crucial insurance reforms—including the prohibition on refusing to cover people with preexisting conditions

Quick Read

Pharma companies don’t have to comply. Large pharmaceutical companies are notoriously risk averse when it comes to expanding access to medications that are still in the testing phase. Many refuse to grant access to investigational drugs outside of clinical trials, and efforts to lobby them to release the medication as part of compassionate use are often rebuffed

Quick Read

The new law has a catchy name, but it will only make it more difficult to know if medication is effective or safe

Quick Read

Our Gail Javitt writes, “The reality is that Right to Try is unlikely meaningfully to increase the number of terminally ill patients who can access investigational therapies or improve the outcomes for such patients. Those that claim otherwise, and who cast FDA as the primary obstacle between dying patients and lifesaving medicines, are peddling their own form of ‘snake-oil'”

Quick Read